Overview

Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema

Status:
Completed
Trial end date:
2018-04-17
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and efficacy of suprachoroidal CLS-TA used with intravitreal aflibercept in subjects with DME.
Phase:
Phase 2
Details
Lead Sponsor:
Clearside Biomedical, Inc.
Treatments:
Aflibercept
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide